Clinical trial
Pericapsular Nerve Group Block for Analgesia After Hip Arthroplasty: a Randomized Double-Blind, Placebo-Controlled Trial.
NCT04231123 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Tivoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pericapsular Nerve Group Block for Analgesia After Hip Arthroplasty: a Randomized Double-Blind, Placebo-Controlled Trial.
- Lead sponsor
- Centre Hospitalier Universitaire de Tivoli
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 20, 2020
- Completion date
- March 15, 2022
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.